How Bromelain Works
Bromelain is not a single enzyme but a complex mixture of cysteine proteases — enzymes that cleave proteins at specific peptide bonds. This activity is responsible for most of its therapeutic effects. When absorbed intact through the gut wall (which happens more readily on an empty stomach), bromelain acts on several inflammatory pathways at once. [1]
Reducing inflammatory mediators: Bromelain suppresses NF-κB signaling, a master regulator of the inflammatory response, and reduces production of pro-inflammatory cytokines including TNF-alpha, IL-1beta, and IL-6. It also inhibits the COX-2 enzyme — the same target as ibuprofen — and reduces prostaglandin synthesis. [1]
Breaking down fibrin: Bromelain has fibrinolytic activity, meaning it helps dissolve the fibrin mesh that forms in injured tissue and contributes to swelling and bruising. This is part of why it's effective for post-surgical edema and sports injuries.
Modulating immunity: At physiological doses, bromelain shifts immune activity in ways that reduce allergic and inflammatory responses without broadly suppressing immunity. [6]
Practical Use and Dosing
Bromelain is measured in enzyme activity units rather than milligrams: GDU (gelatin digesting units) or FIP units are the most common. A typical dose is 500–1000 mg (roughly 1500–3000 GDU), taken two to three times daily on an empty stomach — at least 30 minutes before or 90 minutes after meals. When taken with food, bromelain acts primarily as a digestive enzyme rather than being absorbed systemically.
For joint support and general inflammation, many people start at 500 mg twice daily and adjust based on response. Higher doses (up to 3000 mg/day) have been used in clinical studies without serious adverse effects. [6]
Who should be cautious: People with pineapple allergies should avoid bromelain. It may enhance the absorption of certain antibiotics (particularly amoxicillin and tetracycline) and increase bleeding risk when combined with blood-thinning medications. Pregnant women should avoid therapeutic doses.
Key Applications
Osteoarthritis: Multiple clinical trials have compared bromelain to standard anti-inflammatories for knee pain. A 16-week trial found that 500 mg/day reduced WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) scores significantly, improving pain, stiffness, and physical function. [2] A systematic review concluded that bromelain may provide a safer alternative or adjunctive treatment compared to NSAIDs, with fewer gastrointestinal side effects. [3]
Sinusitis: Bromelain has been prescribed as a pharmaceutical in Germany for acute sinusitis. A pilot study in patients with chronic rhinosinusitis found that 500 FIP units taken orally for three months improved symptom scores and quality of life measures with good tolerability. [4]
Post-surgical recovery: Bromelain is particularly well-studied in oral surgery settings. A systematic review of randomized controlled trials after third molar (wisdom tooth) extraction found large effect sizes for reducing pain, swelling, and quality-of-life impairment during the first postoperative week. [5]
Digestive support: When taken with meals, bromelain helps break down dietary protein, supporting people with low stomach acid or pancreatic insufficiency. This is a different use case from its anti-inflammatory applications.
See the digestive enzymes page for broader context on enzyme supplementation, and the serrapeptase page for a related systemic enzyme with overlapping applications.
Evidence Review
Osteoarthritis
The most robust evidence for bromelain involves joint pain and osteoarthritis. Brien et al. (2004) reviewed all available clinical studies and found consistent evidence of analgesic and anti-inflammatory effects in knee OA, with bromelain comparing favorably to diclofenac in several head-to-head trials — and producing fewer gastrointestinal adverse events. [3]
A more recent randomized single-blind trial by Kasemsuk et al. (2016) enrolled 40 patients with knee OA randomized to receive either oral bromelain (500 mg/day) or diclofenac (100 mg/day) for 16 weeks. By week 16, bromelain-treated patients showed statistically significant improvements in total WOMAC scores (12.2 vs. baseline), pain subscores (2.4), stiffness subscores (0.8), and physical function subscores (9.1). The bromelain group showed comparable functional improvements to the diclofenac group without the known gastrointestinal risks of NSAIDs. [2]
A limitation of the OA literature is that many early trials used multi-enzyme preparations (bromelain combined with trypsin and rutin) rather than bromelain alone, making it difficult to isolate bromelain's contribution. The available evidence suggests clinically meaningful benefit, though the evidence base is smaller than for first-line pharmaceuticals.
Sinusitis
Büttner et al. (2013) conducted a 12-patient prospective pilot study in chronic rhinosinusitis with and without nasal polyps, using 500 FIP bromelain tablets for three months following prior sinus surgery. Preliminary findings showed good symptom control and quality-of-life improvement with no notable adverse effects, supporting larger trials. [4] The authors noted that bromelain appeared more effective in patients without nasal polyps than with them — a potentially important clinical distinction.
Earlier work by Guo et al. and others studying the German pharmaceutical preparation Bromelain-POS in children found statistically significant faster symptom recovery (mean 6.66 days versus 9+ days in comparison groups, p = 0.005). Bromelain is approved as a pharmaceutical for acute sinusitis in Germany.
Oral Surgery
Mendes et al. (2019) conducted a systematic review and meta-analysis of six randomized controlled trials evaluating bromelain following third molar (wisdom tooth) surgery. The pooled analysis found large effect sizes for bromelain's impact on physical appearance (related to swelling), social isolation, and sleep quality in the first postoperative week. Statistically significant reductions in pain intensity were observed at 24 hours and 7 days post-surgery. [5] Heterogeneity across studies was moderate, reflecting different dosing protocols and timing. Overall the evidence supports bromelain as a useful adjunct for post-extraction recovery.
Immunomodulation
Müller et al. (2013) conducted a placebo-controlled randomized double-blind trial examining the immunomodulating effects of oral bromelain at both low dose (1500 mg/day) and high dose (3000 mg/day) in 40 healthy volunteers. Both doses significantly modulated NK cell activity, T-cell subsets, and cytokine production in ways consistent with an anti-inflammatory, immunoregulatory effect. Tolerability was excellent at both doses. [6] This study provided mechanistic confirmation for the immune-mediated effects seen in clinical trials.
Mechanisms
Laboratory and animal research confirms multiple anti-inflammatory pathways. Bromelain downregulates NF-κB signaling and MAPK pathway activation, both central to the inflammatory cascade. It inhibits COX-2 (prostaglandin synthesis) and reduces adhesion molecule expression on immune cells, which limits leukocyte infiltration into inflamed tissue. [1] The fibrinolytic action is well-characterized and provides the rationale for edema reduction after surgery or injury.
Evidence Strength
Moderate. The strongest evidence exists for osteoarthritis and post-surgical recovery, supported by randomized trials and meta-analyses. The sinusitis evidence is preliminary but consistent with mechanistic data. The major limitation across the literature is small sample sizes in most individual trials. Bromelain's safety profile is consistently good, which makes it a reasonable option to consider alongside standard care for appropriate conditions.